Endothelial Dysfunction: The Secret Agent Driving Kidney Disease

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 3-5

  Johnson, Richard J ^a   Nangaku, Masaomi ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SHIGA TOXIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; METALLOPROTEINASE; VASCULOTROPIN A;

DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; HEMOLYTIC UREMIC SYNDROME; HYPERTENSION; KIDNEY DISEASE; METABOLIC SYNDROME X; NONHUMAN; PODOCYTE; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; ANIMAL; ANTAGONISTS AND INHIBITORS; PHYSIOLOGY; THROMBOTIC MICROANGIOPATHIES;

ANIMALS; METALLOENDOPEPTIDASES; THROMBOTIC MICROANGIOPATHIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84954436026     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015050502     Document Type: Review

References (18)

1. Maynard SE, Min JY,Merchan J, Lim KH, Li J,Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1)may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003
2. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649, 2006
3. Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H: The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151: 775-782, 1985
4. Rougier N, Kazatchkine MD, Rougier JP, Fremeaux-Bacchi V, Blouin J, Deschenes G, Soto B, Baudouin V, Pautard B, Proesmans W, Weiss E, Weiss L: Human complement factor H deficiency associated with hemolytic uremic syndrome. J Am Soc Nephrol 9: 2318-2326, 1998
5. Bianchi V, Robles R, Alberio L, Furlan M, Lämmle B: Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: A severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 100: 710-713, 2002
6. Erpenbeck L, Demers M, Zsengeller ZK, Gallant M, Cifuni SM, Stillman IE, Karumanchi SA, Wagner DD: ADAMTS13 endopeptidase protects against vascular endothelial growth factor inhibitor-induced thrombotic microangiopathy. J Am Soc Nephrol 27: 120-131, 2016
7. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003
8. Aref S, Goda H: Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia. Hematology 18: 237-241, 2013
9. Stepanian A, Cohen-Moatti M, Sanglier T, Legendre P, Ameziane N, Tsatsaris V, Mandelbrot L, de Prost D, Veyradier A; ECLAXIR Study Group: VonWillebrand factor and ADAMTS13: A candidate couple for preeclampsia pathophysiology. Arterioscler Thromb Vasc Biol 31: 1703-1709, 2011
10. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai HM, Wagner DD, Ginsburg D: Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 115: 2752-2761, 2005
11. Zheng XL, Sadler JE: Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol 3: 249-277, 2008
12. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007
13. Baylis C: Nitric oxide deficiency in chronic renal disease. Am J Physiol Renal Physiol 294: F1-F9, 2008
14. Cook S,Hugli O, EgliM, Vollenweider P, Burcelin R,Nicod P, Thorens B, Scherrer U: Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133: 360-363, 2003
15. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER,Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625-F631, 2006
16. Clausen T, Slott M, Solvoll K, Drevon CA, Vollset SE, Henriksen T: High intake of energy, sucrose, and polyunsaturatedfatty acids is associatedwith increased risk of preeclampsia. Am J Obstet Gynecol 185: 451-458, 2001
17. Goldberg RJ, Nakagawa T, Johnson RJ, Thurman JM: The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis 56: 1168-1174, 2010
18. Eto N, Kojima I, Uesugi N, Inagi R, Miyata T, Fujita T, Johnson RJ, Shankland SJ, Nangaku M: Protection of endothelial cells by dextran sulfate in rats with thrombotic microangiopathy. J AmSocNephrol 16: 2997-3005, 2005